Buscar
Mostrando ítems 1-10 de 1007
Effects of cyclosporine on adriamycin induced nephropathy
(1998-12-01)
The effect of cyclosporine on adriamycin nephropathy was studied over both short (6 weeks) and long (26 weeks) periods. In the short-term study, cyclosporine was introduced 2 weeks after nephritis induction and in the ...
Effects of cyclosporine on adriamycin induced nephropathy
(1998-12-01)
The effect of cyclosporine on adriamycin nephropathy was studied over both short (6 weeks) and long (26 weeks) periods. In the short-term study, cyclosporine was introduced 2 weeks after nephritis induction and in the ...
Morphometric evaluation of gingival overgrowth and regression caused by cyclosporin in rats
(2001-12-01)
Cyclosporin A is a selective immunosuppressant, used in organ transplants to prevent graft rejection. Cyclosporin A can cause various side effects including gingival overgrowth. The aim of this work was to evaluate gingival ...
Morphometric evaluation of gingival overgrowth and regression caused by cyclosporin in rats
(2001-12-01)
Cyclosporin A is a selective immunosuppressant, used in organ transplants to prevent graft rejection. Cyclosporin A can cause various side effects including gingival overgrowth. The aim of this work was to evaluate gingival ...
The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth
(Amer Acad Periodontology, 1997-09-01)
THE INFLUENCE OF CHEMICAL PLAQUE CONTROL, using topically applied 0.12% chlorhexidine, on the severity of cyclosporin A (CsA)-induced gingival overgrowth (GO) was evaluated. Forty Holtzman rats were divided into four groups: ...
The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth
(Amer Acad Periodontology, 1997-09-01)
THE INFLUENCE OF CHEMICAL PLAQUE CONTROL, using topically applied 0.12% chlorhexidine, on the severity of cyclosporin A (CsA)-induced gingival overgrowth (GO) was evaluated. Forty Holtzman rats were divided into four groups: ...
In vitro study of cyclosporine A 0.05 % on primary and recurrent pterygium fibroblasts
(International Ophthalmology, 2015-08-11)
To compare the cyclosporine 0.05 % exposure effect on fibroblasts from primary and recurrent pterygium. Primary culture of fibroblasts from primary and recurrent pterygium was performed until the third passage, which was ...
Alendronate therapy in cyclosporine-induced alveolar bone loss in rats
(Blackwell Publishing, 2007-10-01)
Background and Objective: Cyclosporine A is an immunosuppressive drug that is widely used in organ transplant patients as well as to treat a number of autoimmune conditions. Bone loss is reported as a significant side-effect ...